CEA (CARCINOEMBRYONIC ANTIGEN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY)/ CEA (ANTÍGENO CARCINOEMBRIONARIO) PRUEBA RÁPIDA CUANTITATIVA (PRUEBA DE INMUNOENSAYO) - INVIMA Registration bf891a8776060e3b19a099e44970f4db

Access comprehensive regulatory information for CEA (CARCINOEMBRYONIC ANTIGEN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY)/ CEA (ANTÍGENO CARCINOEMBRIONARIO) PRUEBA RÁPIDA CUANTITATIVA (PRUEBA DE INMUNOENSAYO) (CEA (CARCINOEMBRYONIC ANTIGEN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY)/ CEA (CARCINOEMBRYONIC ANTIGEN) QUANTITATIVE RAPID TEST (IMMUNOASSAY TEST)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID bf891a8776060e3b19a099e44970f4db and manufactured by DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.. The device was registered on January 05, 2034.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.